A top US lawyer recently spoke at a conference in Washington where he placed focus on four cases for the Supreme Court, two antitrust and two patent cases, as the most important business cases this term. The top advocate for the Supreme Court under the Obama administration, solicitor General Donald Verrilli, made his remarks at an event at Georgetown Law Center. Perhaps most notable is his comment that the Federal Trade Commission, in a way, “won” in the Supreme Court in the court’s unanimous decision in FTC vs. Phoebe Putney Health System; decided last February, the Court ruled that the local hospital authority was not immune to federal antitrust law. Verrilli also mentioned the current FTC vs. Actavis course, which will be argued on March 25 concerning pay-for-delay pharmaceutical deals.
Full Content: Thomson Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Regulator Puts Brakes on £762 Million Logistics Merger Amid Competition Fears
Nov 3, 2024 by
CPI
Nvidia’s Acquisition of AI Startup Run.ai Faces EU Antitrust Review
Nov 3, 2024 by
CPI
Voters Across US to Decide on Landmark Gig Economy Issues on November Ballots
Nov 3, 2024 by
CPI
Court Gives Green Light to $110M Deal in Real Estate Commission Dispute
Nov 3, 2024 by
CPI
Mexico’s First-Ever Class Action Targets Pharma Giants for Price Fixing
Nov 3, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI